NCT03767738View on ClinicalTrials.gov

Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 19, 2018

Primary Completion Date

August 19, 2020

Study Completion Date

August 19, 2020

Conditions
Chorioretinal Vascular Disease
Interventions
DRUG

Intravitreal Aflibercept Injection (IAI)

IAI prepared and administered with a pre-filled syringe (PFS)

Trial Locations (2)

77030

Regeneron Study Site, Houston

77384

Regeneron Study Site, The Woodlands

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT03767738 - Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe | Biotech Hunter | Biotech Hunter